You are here
Home 🌿 Cannabis Technology News 🌿 Israeli And American Companies Create Marijuana Inhaler For Sleep 🌿Israeli And American Companies Create Marijuana Inhaler For Sleep
Insomnia sufferers often swear by a puff of marijuana before bed. Now an Israeli company is helping to medicalize the practice with an inhaler that delivers a stable and controlled dose of a cannabis formula that lasts through the night.
i.can.sleep is a joint venture of iCAN:Israel-Cannabis, a group building out the medical marijuana industry in Israel and CannRx, a U.S. corporation that develops medical applications for cannabis.
The joint venture was announced at CannaTech, a conference on medical marijuana happening in Tel Aviv from March 20-22.
“You take a puff or two depending on the dosage and in ten minutes you will be drowsy enough to sleep,” said William Levine of CannRx.
Israel is poised to give final approval to medical marijuana exports in the coming months. According to Kaye, Israel could reap $1 billion in the next two years.
420 Intel is Your Source for Marijuana News
420 Intel Canada is your leading news source for the Canadian cannabis industry. Get the latest updates on Canadian cannabis stocks and developments on how Canada continues to be a major player in the worldwide recreational and medical cannabis industry.
420 Intel Canada is the Canadian Industry news outlet that will keep you updated on how these Canadian developments in recreational and medical marijuana will impact the country and the world. Our commitment is to bring you the most important cannabis news stories from across Canada every day of the week.
Marijuana industry news is a constant endeavor with new developments each day. For marijuana news across the True North, 420 Intel Canada promises to bring you quality, Canadian, cannabis industry news.
You can get 420 Intel news delivered directly to your inbox by signing up for our daily marijuana news, ensuring you’re always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us on Twitter, Facebook and LinkedIn.